Wall Street reaffirmed a mostly neutral outlook on drug developer Forest Laboratories Inc. Tuesday, after the company posted profits and sales for its third quarter that beat expectations.
From: biz.yahoo.com
Wall Street Reaffirms Views on Forest
Posted by Ruslan Abuzant at 12:29 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment